Corilagin suppresses RANKL‐induced osteoclastogenesis and inhibits oestrogen deficiency‐induced bone loss via the NF‐κB and PI3K/AKT signalling pathways
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Corilagin suppresses RANKL‐induced osteoclastogenesis and inhibits oestrogen deficiency‐induced bone loss via the NF‐κB and PI3K/AKT signalling pathways
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-18
DOI
10.1111/jcmm.15657
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment
- (2019) Hsiu-Jung Liao et al. Cell Death & Disease
- Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis
- (2019) Lu-Jun Li et al. Frontiers in Molecular Neuroscience
- Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis
- (2019) Yanan An et al. FASEB JOURNAL
- Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates
- (2019) Steven R. Cummings et al. JAMA Internal Medicine
- From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights
- (2019) Anesi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- l -tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK-TRAF6 interactions and inhibiting NF-κB and MAPK pathways
- (2019) Xin Zhi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting Macrophages: Friends or Foes in Disease?
- (2019) Juan A. Ardura et al. Frontiers in Pharmacology
- Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis
- (2019) Sivakumar Vijayaraghavalu et al. BIOMATERIALS
- Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading-induced cortical bone loss
- (2019) Jiancheng Yang et al. BONE
- A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage
- (2018) B. Uma Reddy et al. ANTIVIRAL RESEARCH
- Corilagin, a promising medicinal herbal agent
- (2018) Xuan Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model
- (2018) Chen-he Zhou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Corilagin Attenuates Allergy and Anaphylactic Reaction by Inhibiting Degranulation of Mast Cells
- (2018) Jie Zhou et al. MEDICAL SCIENCE MONITOR
- A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5
- (2018) Zhi Xin et al. Frontiers in Pharmacology
- Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling
- (2018) Bin Hu et al. FASEB JOURNAL
- Action of corilagin on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats
- (2018) H.S. Nandini et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
- (2017) Xiao Chen et al. FASEB JOURNAL
- TNF-α promotes osteoclastogenesis through JNK signaling-dependent induction of Semaphorin3D expression in estrogen-deficiency induced osteoporosis
- (2017) Chenglin Sang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail-glycolysis pathways
- (2017) Luoqi Jia et al. ONCOLOGY REPORTS
- Hepatoprotective Effects of Corilagin Following Hemorrhagic Shock are Through Akt-Dependent Pathway
- (2017) Fu-Chao Liu et al. SHOCK
- Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line
- (2017) Rukset Attar et al. OncoTargets and Therapy
- Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis
- (2017) Xiao Chen et al. Cell Death & Disease
- Antioxidant and pro-angiogenic effects of corilagin in rat cerebral ischemia via Nrf2 activation
- (2017) Yi Ding et al. Oncotarget
- DC-STAMP: A Key Regulator in Osteoclast Differentiation
- (2016) Ya-Hui Chiu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Animal models for osteoporosis
- (2015) Toshihisa Komori EUROPEAN JOURNAL OF PHARMACOLOGY
- Management of severe osteoporosis
- (2015) Paul D. Miller EXPERT OPINION ON PHARMACOTHERAPY
- Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro
- (2014) Sang-Gu Yeo et al. ARCHIVES OF PHARMACAL RESEARCH
- A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways
- (2013) Luoqi Jia et al. BMC Complementary and Alternative Medicine
- Corilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrest
- (2013) Yanlin Ming et al. CELL BIOLOGY INTERNATIONAL
- The impact of decreasing U.S. hip fracture rates on future hip fracture estimates
- (2013) J. A. Stevens et al. OSTEOPOROSIS INTERNATIONAL
- Sensitization of Hep3B hepatoma Cells to Cisplatin and Doxorubicin by Corilagin
- (2013) Roberto Gambari et al. PHYTOTHERAPY RESEARCH
- Molecular biology of bone remodeling: Implications for new therapeutic targets for osteoporosis
- (2010) J. Chris Gallagher et al. MATURITAS
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-κB (RANK) expression in myeloid precursor cells
- (2008) Li Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now